Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
LendingTree
TREE
$457M
| $6.52M | 0.01% |
22,534
-38,000
| -63% | -$9.18M |
|
1477
Gencor Industries
GENC
$263M
| $6.48M | 0.01% |
512,947
+32,300
| +7% | +$374K |
|
1478
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.47B
| $6.46M | 0.01% |
57,900
+29,400
| +103% | +$3.22M |
|
1479
Commercial Vehicle Group
CVGI
$130M
| $6.43M | 0.01% |
2,226,181
-290,687
| -12% | -$604K |
|
1480
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.6B
| $6.43M | 0.01% |
193,500
+87,200
| +82% | +$2.89M |
|
|
AEGN
1481
DELISTED
Aegion Corp
AEGN
| $6.42M | 0.01% |
404,296
-54,704
| -12% | -$814K |
|
|
CNCE
1482
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $6.41M | 0.01% |
644,000
+29,000
| +5% | +$278K |
|
|
HR
1483
DELISTED
Healthcare Realty Trust Incorporated
HR
| $6.41M | 0.01% |
218,700
-55,900
| -20% | -$1.67M |
|
|
RVLP
1484
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $6.4M | 0.01% |
951,307
-71,400
| -7% | -$349K |
|
1485
DHI Group
DHX
$173M
| $6.4M | 0.01% |
3,047,778
+29,878
| +1% | +$76.8K |
|
1486
National Fuel Gas
NFG
$7.8B
| $6.39M | 0.01% |
+152,300
| New | +$6.22M |
|
1487
Designer Brands
DBI
$302M
| $6.38M | 0.01% |
942,130
+434,914
| +86% | +$2.63M |
|
|
PFSW
1488
DELISTED
PFSweb, Inc.
PFSW
| $6.37M | 0.01% |
953,700
+229,930
| +32% | +$1.22M |
|
1489
Schrodinger
SDGR
$1.33B
| $6.36M | 0.01% |
+69,500
| New | +$4.05M |
|
|
ZEPP
1490
Zepp Health
ZEPP
$81.4M
| $6.35M | 0.01% |
128,476
-8,235
| -6% | -$380K |
|
1491
LSI Industries
LYTS
$907M
| $6.33M | 0.01% |
979,141
-129,630
| -12% | -$748K |
|
1492
Fossil Group
FOSL
$324M
| $6.33M | 0.01% |
1,361,050
+1,071,155
| +369% | +$4.11M |
|
1493
Heritage Insurance Holdings
HRTG
$1B
| $6.3M | 0.01% |
481,100
+27,800
| +6% | +$325K |
|
1494
CAE Inc. Common Shares
CAE
$8.45B
| $6.29M | 0.01% |
388,619
-890,027
| -70% | -$13.8M |
|
1495
JELD-WEN Holding
JELD
$165M
| $6.28M | 0.01% |
390,088
-384,600
| -50% | -$5.07M |
|
|
EXPR
1496
DELISTED
Express, Inc.
EXPR
| $6.28M | 0.01% |
203,905
-18,560
| -8% | -$684K |
|
1497
Dell
DELL
$317B
| $6.28M | 0.01% |
+225,469
| New | +$5.07M |
|
|
SEM
1498
DELISTED
Select Medical
SEM
| $6.26M | 0.01% |
789,357
-1,570,918
| -67% | -$13M |
|
|
MAXR
1499
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $6.25M | 0.01% |
348,202
-100,027
| -22% | -$1.29M |
|
1500
Atlanta Braves Holdings Series A
BATRA
$3.69B
| $6.25M | 0.01% |
311,400
+39,300
| +14% | +$798K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.